EpiPen Maker Hopes A Generic Version Will End The Pricing Controversy
Mylan announced that a nonbranded version of the allergy drug will be sold at half the price.By Ryan Biek | August 29, 2016
The maker of the EpiPen is hoping to end the surrounding controversy by offering a generic version of the life-saving drug.
Pharmaceutical company Mylan announced Monday it will launch an alternative to the EpiPen at half the price.
While the cost of two generic injectors of the emergency allergy drug will still be pricey at $300, Mylan has been facing severe criticism for the $600 price tag for a pair of EpiPens.